Literature DB >> 1696469

A transgenic mouse model for trilateral retinoblastoma.

J M O'Brien1, D M Marcus, R Bernards, J L Carpenter, J J Windle, P Mellon, D M Albert.   

Abstract

We present a murine model of trilateral retinoblastoma. Ocular retinoblastoma and central nervous system tumors are observed in a line of mice formed by the transgenic expression of SV40 T-antigen. An oncogenic protein known to bind to the retinoblastoma gene product (p105-Rb) is specifically expressed within retinal cells in this model. All animals that carry this genetic alteration develop multifocal retinal tumors. Midbrain tumors are observed in 15% of ocular tumor-bearing animals, and these arise ventral to the cerebral aqueduct at the level of the pineal gland. Both ocular and central nervous system neoplasms are heritable in heterozygous offspring through 10 sequential generations of breeding. Retinal tumors display the gross appearance, invasive properties, light and electron microscopic features, and immunohistochemical staining characteristics of human retinoblastoma. The light and electron microscopic characteristics as well as immunocytochemical features of undifferentiated midline central nervous system neoplasms further correlate with human trilateral retinoblastoma. We postulate an alternative mechanism of retinoblastoma tumorigenesis that involves functional inactivation of retinoblastoma protein locally in the face of an intact retinoblastoma gene locus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696469     DOI: 10.1001/archopht.1990.01070100101043

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

Review 1.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

2.  The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.

Authors:  Sanja Pajovic; Timothy W Corson; Clarellen Spencer; Helen Dimaras; Marija Orlic-Milacic; Mellone N Marchong; Kwong-Him To; Brigitte Thériault; Mark Auspitz; Brenda L Gallie
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

3.  Transgenic models of retinoblastoma: what they tell us about its cause and treatment.

Authors:  D M Albert; A E Griep; P F Lambert; K A Howes; J J Windle; J G Lasudry
Journal:  Trans Am Ophthalmol Soc       Date:  1994

4.  Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice.

Authors:  M R al-Ubaidi; J G Hollyfield; P A Overbeek; W Baehr
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 5.  Use of preclinical models to improve treatment of retinoblastoma.

Authors:  Michael A Dyer; Carlos Rodriguez-Galindo; Matthew W Wilson
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

6.  Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model.

Authors:  Xiaoyun Chen; Jian Wang; Ziquan Cao; Kayoko Hosaka; Lasse Jensen; Huasheng Yang; Yuping Sun; Rujie Zhuang; Yizhi Liu; Yihai Cao
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

7.  Lack of effect of SU1498, an inhibitor of vascular endothelial growth factor receptor-2, in a transgenic murine model of retinoblastoma.

Authors:  C M Cebulla; M E Jockovich; H Boutrid; Y Piña; M Ruggeri; S Jiao; S K Bhattacharya; W J Feuer; T G Murray
Journal:  Open Ophthalmol J       Date:  2008-04-02

8.  Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice.

Authors:  Nisha V Shah; D G Pham; T G Murray; C Decatur; E Hernandez; Nikesh N Shah; M Cavalcante; S K Houston
Journal:  J Ophthalmol       Date:  2014-03-10       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.